Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Bianca Jc van den Bosch"'
Autor:
Jörgen Bierau, Marieke J H Coenen, Judith de Vos-Geelen, Charlotte W. Ockeloen, Bianca Jc van den Bosch, Manon Hijmans-van der Vegt, Annelieke Ecab Willemsen, Aron Raaijmakers
Publikováno v:
Journal of Oncology Pharmacy Practice, 29, 5-13
Journal of Oncology Pharmacy Practice, 29(1):10781552211049144, 5-13. SAGE Publications Inc.
Journal of Oncology Pharmacy Practice, 29, 1, pp. 5-13
Journal of Oncology Pharmacy Practice, 29(1), 5-13. SAGE Publications Ltd
Journal of Oncology Pharmacy Practice, 29(1):10781552211049144, 5-13. SAGE Publications Inc.
Journal of Oncology Pharmacy Practice, 29, 1, pp. 5-13
Journal of Oncology Pharmacy Practice, 29(1), 5-13. SAGE Publications Ltd
Decreased dihydropyrimidine dehydrogenase enzyme activity is associated with severe fluoropyrimidine-associated toxicity. Four clinically relevant variants in the DPYD gene are associated with decreased dihydropyrimidine dehydrogenase activity. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33feca5e57b760a3acc28fad217b0173
https://doi.org/10.1177/10781552211049144
https://doi.org/10.1177/10781552211049144
Autor:
Charlotte W, Ockeloen, Aron, Raaijmakers, Manon, Hijmans-van der Vegt, Jörgen, Bierau, Judith, de Vos-Geelen, Annelieke Ecab, Willemsen, Bianca Jc, van den Bosch, Marieke Jh, Coenen
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 29(1)
To investigate if dihydropyrimidine dehydrogenase phenotyping has added value when combined withRetrospective cohort study in which treatment and toxicity data were collected of 228 patients genotyped for fourSevere toxicity occurred in 25% of patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::30e7a81ba952259471da317a45d863ab
https://pubmed.ncbi.nlm.nih.gov/34797200
https://pubmed.ncbi.nlm.nih.gov/34797200